Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Positive Regulator Molecules02:39

Positive Regulator Molecules

5.3K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.3K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
Separation of Sister Chromatids02:17

Separation of Sister Chromatids

3.5K
At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
3.5K
Microtubule Instability02:17

Microtubule Instability

4.9K
Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ZHMolTopoRPI: A Commutative Algebra-Driven Deep Learning Framework for Robust RNA-Protein Interaction Prediction.

Journal of chemical information and modeling·2026
Same author

Molecular characterization and pathogenicity of a HP-like PRRSV strain and a NADC30 recombinant strain.

Microbial pathogenesis·2026
Same author

Exploring ligand flexibility in nucleic acid scaffolds using graph neural networks.

Biophysical journal·2026
Same author

Lactylation in cardiac repair: Nexus and therapeutic opportunity.

Journal of molecular and cellular cardiology plus·2026
Same author

A method for collapse pressure analysis while drilling through fractured clay formations.

Scientific reports·2026
Same author

SIRT3-mediated deacetylation of ATP5A1 improves mitochondrial function to attenuate myocardial ischemia-reperfusion injury.

Biochemical and biophysical research communications·2026

Related Experiment Video

Updated: May 17, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.2K

Dynamics insights into CDK4/6-CyclinD1 complex stability modulated by abemaciclib.

Yuqing Zhao1, Chen Zhuo1, Haoquan Liu1

  • 1Institute of Biophysics and Department of Physics, Central China Normal University, Wuhan, 430079, China. yjzhaowh@ccnu.edu.cn.

Physical Chemistry Chemical Physics : PCCP
|May 16, 2025
PubMed
Summary
This summary is machine-generated.

Abemaciclib disrupts the CDK4-CyclinD1-P21 complex, with P21 binding more strongly to CDK4 than CDK6. This finding improves understanding of CDK4/6 inhibitors for cancer therapy.

More Related Videos

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

18.5K
Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
08:33

Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis

Published on: December 5, 2017

14.2K

Related Experiment Videos

Last Updated: May 17, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.2K
Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

18.5K
Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
08:33

Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis

Published on: December 5, 2017

14.2K

Area of Science:

  • Molecular biology
  • Cancer research
  • Pharmacology

Background:

  • The CDK4/6-CyclinD1 complex regulates the cell cycle and is implicated in cancer.
  • P21 and P27 are crucial for cell cycle G1/S transition.
  • Abemaciclib is a CDK4/6 inhibitor, but its precise effects on complex stability are not fully understood.

Purpose of the Study:

  • To investigate the impact of abemaciclib on the stability of the CDK4/6-CyclinD1-P21/P27 complex.
  • To elucidate the binding mechanisms and affinities of P21 to CDK4 and CDK6 in the presence of abemaciclib.
  • To identify specific regions within CDK4/6 involved in abemaciclib's mechanism of action.

Main Methods:

  • Molecular dynamics (MD) simulations.
  • Residue decomposition analysis.
  • Relative Interaction Network (RIN) analysis.
  • Generation of CDK4 C-terminus mutants.

Main Results:

  • P21 exhibits higher binding affinity to CDK4 compared to CDK6, involving a broader range of residues.
  • Abemaciclib disrupts the C-lobe region of CDK4 within the CDK4-CyclinD1-P21 complex.
  • A CDK4 C-terminus mutant selectively modulated abemaciclib's effect on P21 binding affinity.

Conclusions:

  • Abemaciclib's mechanism involves disrupting the CDK4-CyclinD1-P21 complex stability via non-catalytic regions.
  • Findings enhance understanding of second-generation CDK4/6 inhibitors.
  • Future inhibitors may further destabilize CDK6- and P27-containing complexes to improve cancer therapy efficacy.